Gilead Sciences (NASDAQ:GILD) announced an additional $11B in capital and operational investments in the U.S. on Wednesday. The $11B investment adds onto an already planned spend of $21B in U.S.

Gilead Sciences adds $11B to its U.S. investment plan, boosting manufacturing, R&D, and job creation. Read more here.